Contribution of socioeconomic risk factors within a diverse mycosis fungoides cohort from Detroit, Michigan

Demographic factors and disparate outcomes in mycosis fungoides: retrospective analysis of a racially diverse 440‐patient cohort from Detroit, Michigan, USA

“…Mycosis fungoides diagnosis was confirmed via physician note review for 440 patients in the Henry Ford Health System, as recently reported 6 . Progression‐free survival (PFS) was calculated from the date of diagnostic biopsy to the first documented progression in clinical stage or death, or, for those without documented progression, the most recent follow‐up with an MF specialist.…”

“…Mycosis fungoides diagnosis was confirmed via physician note review for 440 patients in the Henry Ford Health System, as recently reported. 6 Progression-free survival (PFS) was calculated from the date of diagnostic biopsy to the first documented progression in clinical stage or death, or, for those without documented progression, the most recent follow-up with an MF specialist. Kaplan-Meier survival curves were used to compare the probability of outcomes between groups divided by sex, race and age at diagnosis (younger, < 40 years old; older, ≥ 40), with cutoffs chosen based on literature convention.…”

“…The deficit of dermatologists was forecasted using the disability-adjusted life-year (DALY). 6 A DALY represents a lost year of 'healthy' life, thus measuring burden of disease. The DALY load per dermatologist was 1254 for SA (2019) (Figure 1), which is lower than in other African countries such as 1313 for Botswana (2021) and 6085 for Namibia (2021), but higher than in developed countries, such as 814 for the UK (2012) and 211 for the USA (2015).…”

Influence of medical comorbidities, smoking, and alcohol on mycosis fungoides progression and mortality

“…Patients in the Henry Ford Health (HFH) MF registry (n = 440) 1,2 were included in this retrospective study (Table 1).…”

“…Further details on inclusion criteria and cohort characteristics of this registry have been previously discussed 1,2. ª 2023 the International Society of Dermatology.International Journal of Dermatology 2024, 63, e33-e73 e33…”